Back to Agenda
TOPIC 2 SESSION 1 CONTINUED: SUSAR Reporting in Clinical Trials and Case Studies
Session Chair(s)
Gaby L. Danan, MD, PHD
Pharmacovigilance Expert, GLD, France
Phil Tregunno
Deputy Director - Patient Safety Monitoring, Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Speaker(s)
Gaby L. Danan, MD, PHD
Pharmacovigilance Expert, GLD, France
SUSAR Reporting in Clinical Trials and Case Studies
Have an account?